Minute Insight: ForSight Nabs $55M In Series A Funding To Develop Fully Automated Robot For Eye Surgery
ForSight Robotics said after applying its robotic technology successfully in animals, it will use the new funding to test the technology in clinical trials.
You may also be interested in...
In this second roundup of HLTH, which drew more than 9,000 attendees to Las Vegas from 13-16 November, Medtech Insight highlights presentations from the CEOs of BD and Google Cloud and insights from an interview with BD’s CEO Tom Polen.
A newly cleared Apple Watch app will allow people living with Parkinson’s to more easily track tremors, dyskinesia and other symptoms.
Edwards Lifesciences CEO Mike Mussallem has a unique and long-standing perspective of what the medtech industry should be and do. In over two decades, he has built the structural heart disease and critical care monitoring company into one of the global medtech industry’s most effective innovators.